Vimarsana
Biggest News Aggregation in the World

Page 2 - Robert Stanislaro News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Stanislaro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Stanislaro Today - Breaking & Trending Today

ProQR Announces Third Quarter 2023 Operating and Financial Results - Vimarsana News

ProQR Announces Third Quarter 2023 Operating and Financial Results

Continued advancement of platform and initial pipeline programs with liver delivery to address Cholestatic Diseases targeting NTCP and Cardiovascu...

ProQR Strengthens Leading Intellectual Property Estate for ADAR-mediated RNA Editing - Vimarsana News

ProQR Strengthens Leading Intellectual Property Estate for ADAR-mediated RNA Editing

LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicate...

ProQR Announces Participation in the Chardan 7th Annual Genetic Medicines Conference - Vimarsana News

ProQR Announces Participation in the Chardan 7th Annual Genetic Medicines Conference

LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 28, 2023 -- ProQR Therapeutics NV. , a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer® RNA...

ProQR Therapeutics Provides Update on Ophthalmic Assets - Vimarsana News

ProQR Therapeutics Provides Update on Ophthalmic Assets

LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies today provided an update that its previously announced agreement to divest the Company’s late-stage ophthalmic assets to Laboratoires Théa S.A.S. (Théa) has been terminated. The completion of the transaction was conditional on Théa entering into employment agreements with a number of key ophthalmology

Source: yahoo.com
ProQR Announces Second Quarter 2023 Operating and Financial Results - Vimarsana News

ProQR Announces Second Quarter 2023 Operating and Financial Results

Divestment of sepofarsen and ultevursen ophthalmic programs supports ProQR’s strategic focus on Axiomer® RNA editing platform technology and continued advancement of pipeline€129 M cash and cash equivalents as of June 30, 2023 providing runway into mid-2026 LEIDEN, Netherlands & CAMBRIDGE, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer® RNA editing

Source: yahoo.com